These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2877865)
1. Evidence that growth hormone-releasing factor stimulates somatostatin release in vitro via beta-endorphin. Aguila MC; McCann SM Endocrinology; 1987 Jan; 120(1):341-4. PubMed ID: 2877865 [TBL] [Abstract][Full Text] [Related]
2. The effect of galanin on growth hormone-releasing factor and somatostatin release from median eminence fragments in vitro. Aguila MC; Marubayashi U; McCann SM Neuroendocrinology; 1992 Dec; 56(6):889-94. PubMed ID: 1285434 [TBL] [Abstract][Full Text] [Related]
3. Stimulation of somatostatin release in vitro by synthetic human growth hormone-releasing factor by a nondopaminergic mechanism. Aguila MC; McCann SM Endocrinology; 1985 Aug; 117(2):762-5. PubMed ID: 2862013 [TBL] [Abstract][Full Text] [Related]
4. Calmodulin dependence of somatostatin release stimulated by growth hormone-releasing factor. Aguila MC; McCann SM Endocrinology; 1988 Jul; 123(1):305-9. PubMed ID: 2898360 [TBL] [Abstract][Full Text] [Related]
5. Role of arachidonic acid or its metabolites in growth-hormone-releasing factor-induced release of somatostatin from the median eminence. Aguila MC; Milenkovic L; McCann SM; Snyder GD Neuroendocrinology; 1990 Sep; 52(3):238-42. PubMed ID: 1977095 [TBL] [Abstract][Full Text] [Related]
6. Alpha-melanocyte stimulating hormone discloses a stimulatory effect of beta-endorphin on somatostatin release. Aguila MC; Khorram O; McCann SM Brain Res; 1987 Aug; 417(1):127-30. PubMed ID: 2887255 [TBL] [Abstract][Full Text] [Related]
7. The inhibition of growth hormone release by gastrin-releasing peptide involves somatostatin release. Kentroti S; Aguila MC; McCann SM Endocrinology; 1988 Jun; 122(6):2407-11. PubMed ID: 2897283 [TBL] [Abstract][Full Text] [Related]
8. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats. Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532 [TBL] [Abstract][Full Text] [Related]
9. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men. Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361 [TBL] [Abstract][Full Text] [Related]
10. Paradoxical enhancement of pituitary growth hormone (GH) responsiveness to GH-releasing factor in the face of high somatostatin tone. Tannenbaum GS; Painson JC; Lengyel AM; Brazeau P Endocrinology; 1989 Mar; 124(3):1380-8. PubMed ID: 2563683 [TBL] [Abstract][Full Text] [Related]
11. Effects of rat growth hormone (rGH)-releasing factor and somatostatin on the release and synthesis of rGH in dispersed pituitary cells. Fukata J; Diamond DJ; Martin JB Endocrinology; 1985 Aug; 117(2):457-67. PubMed ID: 2862007 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of platelet-activating factor (PAF) on luteinizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with the characterization of specific PAF receptor sites in rat hypothalamus. Junier MP; Tiberghien C; Rougeot C; Fafeur V; Dray F Endocrinology; 1988 Jul; 123(1):72-80. PubMed ID: 2898362 [TBL] [Abstract][Full Text] [Related]
13. Combined effects of human growth hormone (GH)-releasing factor-44 (GRF) and somatostatin (SRIF) on post-SRIF rebound release of GH and prolactin: a model for GRF-SRIF modulation of secretion. Stachura ME; Tyler JM; Farmer PK Endocrinology; 1988 Sep; 123(3):1476-82. PubMed ID: 2900135 [TBL] [Abstract][Full Text] [Related]
14. Physiologically significant effect of neuropeptide Y to suppress growth hormone release by stimulating somatostatin discharge. Rettori V; Milenkovic L; Aguila MC; McCann SM Endocrinology; 1990 May; 126(5):2296-301. PubMed ID: 1970290 [TBL] [Abstract][Full Text] [Related]
15. Somatostatin-stimulated growth hormone-releasing factor secretion in vitro is modified by fetal ethanol exposure. Conway S; Swain R Alcohol Clin Exp Res; 1997 Jun; 21(4):703-9. PubMed ID: 9194927 [TBL] [Abstract][Full Text] [Related]
16. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor. Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164 [TBL] [Abstract][Full Text] [Related]
17. Effect of withdrawal of somatostatin and growth hormone (GH)-releasing factor on GH release in vitro. Kraicer J; Sheppard MS; Luke J; Lussier B; Moor BC; Cowan JS Endocrinology; 1988 May; 122(5):1810-5. PubMed ID: 2896117 [TBL] [Abstract][Full Text] [Related]
18. Effect of somatostatin withdrawal and growth hormone (GH)-releasing factor on GH release in vitro: amount available for release after disinhibition. Kraicer J; Cowan JS; Sheppard MS; Lussier B; Moor BC Endocrinology; 1986 Nov; 119(5):2047-51. PubMed ID: 2876882 [TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor I modulates hypothalamic somatostatin through a growth hormone releasing factor increased somatostatin release and messenger ribonucleic acid levels. Aguila MC; Boggaram V; McCann SM Brain Res; 1993 Oct; 625(2):213-8. PubMed ID: 7903898 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of hypothalamic medial preoptic area somatostatin on growth hormone-releasing factor in the rat. Katakami H; Downs TR; Frohman LA Endocrinology; 1988 Aug; 123(2):1103-9. PubMed ID: 2899498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]